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Abstract Several analogues of 7-O- and 40-O-substituted
isoxanthohumol and 8-prenylnaringenin, the strongest known
phytoestrogen and potential anticancerogenic agent, were
synthesized. Acyl, alkyl, and allyl derivatives of isoxanthohu-
mol underwent the demethylation process using MgI2 9
2Et2O in anhydrous THF with the yields of 61–89%. Some of
the compounds approached the international criteria of anti-
proliferative activity (4 lg/ml) for synthetic agents against the
human cancer cell lines.
Keywords Hop flavonoids  Phytoestrogens 
Antitumor agents  Antiproliferative activity 
MCF-7  HT-29  CCRF/CEM
Introduction
Hops (Humulus lupulus L.) are used in the brewing
industry to add flavor and bitterness to beer. They consist
of many prenylated chalcones and flavanones (Stevens and
Page, 2004). Among them, xanthohumol (1) has received
much attention in recent years as an anti-cancer (Colgate
et al., 2007; Drenzek et al., 2011; Okano et al., 2011),
antioxidant (Delmulle et al., 2006; Jacob et al., 2011), and
anti-HIV (Cos et al., 2008) agent. It is readily accessible
from carbon dioxide-extracted-hops (spent hop) where its
content ranges up to 1% of dry matter. Spent hop is an
important by-product of the process of hop extraction in the
beer brewing industry, which is usually used as a fertilizer
or as an animal feed in the U.S. However, in order to
increase the added value of spent hops, hop processing
industries have been looking for an alternative utilization
of spent hops (Faltermeier et al., 2006; Oosterveld et al.,
2002). Other flavonoids, isoxanthohumol (2) and 8-pren-
ylnaringenin (3) are also present in hops, but in ten to one
hundred times lower concentrations than the content of 1
(Stevens et al., 2000). Compound (3) is the potential drug
in menopausal hormone therapy and the strongest phyto-
estrogen known in the nature (Borrelli and Ernst, 2010;
Bo¨ttner, 2008; Chadwick et al., 2006; Hyun et al., 2008;
Overk et al. 2008). The compounds (1–3) have also anti-
breast cancer activity (Brunelli et al., 2007; Monteiro et al.,
2007; Wesolowska et al., 2010a, b). Prenylflavonoid (3)
can be synthesized in high yield from xanthohumol (1). It
requires the cyclization of 1 to isoxanthohumol (2) in basic
conditions and demethylation of 2–3 with MgI2 9 2Et2O
(Anioł et al., 2008).
Wilhelm and Wessjohann, (2006) studied demethylation
of 2–3 with AlBr3, BBr3 or MeAlCl2 in collidine; ZnBr2,
CuI, ZnBr2/CuI Yb2(SO4)3/KI or CuI, Sm(OTf)3/KI,
CeCl3/LiI. Product (3) was not detected or obtained with
low yield. Hydroxyl groups of 2 were also protected with
chlorotriisopropylsilane, demethylated with AlBr3 and
deprotected with (n-Bu)4NF to obtain 8-prenylnaringenin
(3) with 73% yield. The best result was obtained for
Sc(OTf)3/KI (92%).
Magnesium iodide etherate was previously applied in
the regioselective demethylation of 5-acetyl-4,6-dime-
thoxy-2-isopropenyl-2,3-dihydrobenzofuran (Yamaguchi
et al., 1987) and substituted 2,6-dimethoxybenzaldehydes
(Yamaguchi et al., 1999).
Only a few studies can be found in the literature that
reported 8-prenylnaringenin and isoxanthohumol deriva-
tive synthesis. Methylation of 8-prenylnaringenin (3) with
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Me2SO4 resulted in the formation of di-O-methyl deriva-
tives of 1 and 2 (Jain et al., 1978). The synthesis of
7,40-di-O-acetyl-8-prenylnaringenin was carried out using
7,40-di-O-acetylnaringenin as a substrate via its 4-O-prenyl
ether, which undertook the Claisen–Cope rearrangement
(Gester et al., 2001). The preparation of chiral 7,40-dime-
thyl- or diacetyl- isoxanthohumols and 8-prenylnaringenins
was achieved by reducing a carbonyl group to a hydroxyl
group with a mixture of formic acid and a base in the
presence of chiral catalyst. Separation of the non-trans-
ferred enantiomer (2S) or (2R) of the reduced 8-prenylna-
ringenin diacetyl derivative and splitting the acyl residues in
enantiomers by enzyme catalyst solvolysis gave (2S)-8-
prenylnaringenin or (2R)-8-prenylnaringenin. The second
enantiomers (2R) or (2S) of 8-prenylnaringenin diacetyl
derivative was recovered by oxygenation of a hydroxyl
group (Metz and Schwab, 2007). Starting from 3, several
carboxylic acid haptenes of this compound were also syn-
thesized. Five linkers [–(CH2)nCOOH, n = 1, 3, 5, 6, and 9]
were coupled to the C7–OH or C40–OH group of 8-pren-
ylnaringenin to obtain five derivatives (Schaefer et al., 2005).
In this article, we report methods of synthesis of 7-O-
and 40-O-substituted alkyl, alkenyl and acyl isoxanthohu-
mol derivatives and their demethylation using magnesium
iodide etherate. This research is connected with utilization
of the spent hop, obtained after extraction with supercriti-
cal carbon dioxide. This waste product of the hop industry
is rich in xanthohumol, the starting compound in the syn-




All the reactions were carried out under a dry nitrogen
atmosphere. The organic solvents were dried and purified
according to the standard procedures. The reagents were
purchased from Fluka. Isoxanthohumol (2) was obtained
from xanthohumol (1) by dissolving in 1% NaOH and
acidification of the reaction mixture as it was described
previously (Anioł et al., 2008). Analytical thin-layer
chromatography was carried out on DC-Alufolien Kiesel-
gel 60 F254 silica gel (0.2 mm; Merck) with chloroform:
methanol (96:4) as the developing solvent. Visualization
was effected with a solution of 10 g Ce (SO4)2 and 20 g
phosphomolybdic acid in 1 l of 10% H2SO4, followed by
heating. Preparative column chromatography was accom-
plished using silica gel (Kiesel 60, 230–400 mesh; Merck)
columns. Proton NMR spectra were recorded on a Bruker
AMX 300 instrument at 300 MHz with acetone-d6 as the
solvent and TMS as an internal standard. The infrared (IR)
spectra in KBr were recorded on a Mattson IR 300
spectrometer.
Synthesis of isoxanthohumol derivatives
7,40-Di-O-methylisoxanthohumol (4) and 7-O-meth-
ylisoxanthohumol (5) A mixture of isoxanthohumol (100
mg, 0.282 mmol), anhydrous K2CO3 (232 mg, 1.68 mmol),
and methyl iodide (0.5 ml) in 5 ml of anhydrous acetone was
stirred for 12 h at room temperature. Acetone was evaporated
and the resultant reaction mixture was treated with 10 ml of
a saturated NaCl solution and extracted with Et2O (3 9
10 ml). The organic phase was dried over anhydrous Na2SO4,
concentrated and was subjected to column chromatography
(CHCl3:MeOH, 99:1) to provide 74.9 mg (69.4%) of light
yellow solid (mp = 37–39C, Rf = 0.60, CHCl3:MeOH,
98:2) of 7,40-di-O-methylisoxanthohumol (4) and 9.1 mg
(8.8%) of white solid (mp = 181–184C, Rf = 0.21, CHCl3:
MeOH, 98:2) of 7-O-methylisoxanthohumol (5). 1H NMR
and IR spectroscopic data were in agreement with those
reported in the literature (Metz and Schwab, 2007; Stevens
et al., 2000).
7-O-n-pentylisoxanthohumol (6) and 7,40-di-O-n-pentyl-8-
isoxanthohumol (7) The reaction was carried out exactly in
the same way as it is described for compounds (4 and 5) but
1 ml of n-pentyl iodide was used instead of methyl iodide.
The product (33.5 mg, 27.6%) 7-O-n-pentylisoxanthohumol
(6) was obtained as a pale yellow solid (mp = 140–142C,
Rf = 0.61, CHCl3:MeOH, 97:3). The
1H NMR (300 MHz,
acetone-d6) for compound (6): d (ppm): 0.93 (t, 3H,
J = 7.1 Hz, C-7–O(CH2)4CH3); 1.33–1.54 (m, 4H, C-7–
O(CH2)2CH2CH2CH3); 1.61 (d, 6H, J = 1.3 Hz, CH3-4
00
and CH3-5
00); 1.78–1.87 (m, 2H, C7–OCH2CH2(CH2)2CH3);
2.63 (dd, 1H, J = 16.4 Hz, J = 3.0 Hz, CH-3); 2.93 (dd,
1H, J = 16.4 Hz, J = 12.5 Hz, CH-3); 3.26 (d, 2H,
J = 7.1 Hz, CH2-1
00); 3.84 (s, 3H, C-5–OCH3); 4.13 (t, 2H,
J = 6.3 Hz, C-7–OCH2(CH2)3CH3); 5.16 (tsept, 1H, J =
7.1 Hz, J = 1.3 Hz, CH-200); 5.36 (dd, 1H, J = 12.5 Hz,
J = 3.0 Hz, CH-2); 6.34 (s, 1H, CH-6); 6.89(d, 2H,
J = 8.6 Hz, CH-30 and CH-50); 7.38 (d, 2H, J = 8.6 Hz,
CH-20 i CH-60); 8.53 (s, 1H, C-40–OH). IR (KBr) cm-1: 2957,
2931, 2856, 1665, 1599, 1570, 1520, 1458, 1262, 1103, 798.
C26H32O5 (424.54): calcd. C 73.56, H 7.60; found C 73.67, H
6.75. The compound 7,40-di-O-n-pentyl-8-isoxanthohumol
(7) was also isolated (18.4 mg, 13.6% yield) as a light yellow
solid (mp = 70–75C, Rf = 0.87, CHCl3:MeOH, 97:3). 1H
NMR (300 MHz, acetone-d6) d (ppm): 0.93 (t, 6H,
J = 7.1 Hz, C-7- and C-400–O(CH2)4CH3); 1.34-1.54 (m,
8H, C-7- and C-40-O(CH2)2CH2CH2CH3); 1.62 (d, 6H,
J = 1.3 Hz, CH3-4
00 and CH3-500); 1.74–1.87 (m, 4H, C-7-
and C40–OCH2CH2(CH2)2CH3); 2.65 (dd, 1H, J = 16.3 Hz,
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J = 3.0 Hz, CH-3); 2.95 (dd, 1H, J = 16.3 Hz,
J = 12.5 Hz, CH-3); 3.28 (d, 2H, J = 7.1 Hz, CH2-1
00);
3.84 (s, 3H, C-5–OCH3); 4.02 (t, 2H, J = 6.5 Hz, C-4
0–
OCH2(CH2)3CH3); 4.13 (t, 2H, J = 6.3 Hz, C-7–OCH2
(CH2)3CH3); 5.17 (tsept, 1H, J = 7.1 Hz, J = 1.3 Hz, CH-
200); 5.43 (dd, 1H, J = 12.5 Hz, J = 3.0 Hz, CH-2); 6.34 (s,
1H, CH-6); 6.98 (d, 2H, J = 8.7 Hz, CH-30 and CH-50); 7.46
(d, 2H, J = 8.7 Hz, CH-20 and CH-60). IR (KBr) cm-1: 3064,
2952, 2936, 2870, 1675, 1601, 1577, 1517, 1465, 1346, 1253,
1113, 827. C31H42O5 (494.68): calcd. C 75.27, H 8.56; found
C 75.51, H 8.44.
7,40-Di-O-allylisoxanthohumol (8) The reaction was car-
ried out similarly as it is described for compounds (4 and 5) but
1 ml of allyl bromide and 6 ml of anhydrous THF were used
instead methyl iodide and acetone. The product was purified
by column chromatography (CHCl3:MeOH, 99.3:0.7) to give
100.2 mg of 7, 40-di-O-allylisoxanthohumol (8) as a light
yellow solid (mp = 79–83C, Rf = 0.85, CHCl3:MeOH,
95:5) with 81.2% yield. 1H NMR (300 MHz, acetone-d6) d
(ppm): 1.61 (d, 6H, J = 1.4 Hz, CH3-4
00 and CH3-500); 2.66
(dd, 1H, J = 16.3 Hz, J = 3.1 Hz, CH-3); 2.95 (dd, 1H,
J = 16.3 Hz, J = 12.5 Hz, CH-3); 3.28 (d, 2H, J = 7.2 Hz,
CH2-1
00); 3.84 (s, 3H, C-5–OCH3); 4.61 and 4.73 (two ddd,
4H, J = 5.2 Hz, J = 1.7 Hz, J = 1.5 Hz, C-7- and C-40–
OCH2CH=CH2); 5.18 (tsept, 1H, J = 7.2 Hz, J = 1.4 Hz,
CH–200); 5.25 and 5.29 (two dq, 2H, J = 10.4 Hz, J = 1.5 Hz
and J = 10.4 Hz, J = 1.5 Hz, trans-C-7- and trans-C-40–
OCH2CH=CH2); 5.42 (dd, 1H, J = 12.5 Hz, J = 3.1 Hz,
CH-2); 5.41 and 5.47 (two dq, 2H, J = 8.8 Hz, 1.7 Hz,
J = 8.8 Hz, 1.7 Hz, cis-C-7- and cis-C-40-OCH2CH=CH2);
6.09 and 6.11 (two ddt, 2H, J = 10.4 Hz, J = 8.8 Hz, 5.2 Hz
i J = 10.4 Hz, J = 8.8 Hz, 5.2 Hz, C-7- i C-40–OCH2
CH=CH2); 6.36 (s, 1H, CH-6); 7.01(d, 2H, J = 8.7 Hz, CH-3
0
and CH-50); 7.48 (d, 2H, J = 8.7 Hz, CH-20 and CH-60). IR
(KBr) cm-1: 3080, 2985, 2962, 2915, 2852, 1678, 1604, 1574,
1515, 1272, 1116, 1018, 932, 821. C27H30O5 (434.54): calcd.
C 74.63, H 6.96; found C 74.70, H 7.02.
7,40-Di-O-acetylisoxanthohumol (9) To a solution of
100 mg (0.282 mmol) of isoxanthohumol and 0.37 ml
(2.8 mmol) of Et3N in 7.4 ml of anhydrous THF was added
dropwise acetic anhydride 0.13 ml, 1.4 mmol). After 12 h
of stirring at room temperature, the reaction medium was
shaken with 36 ml of cooled water. The precipitated
crystals were separated, washed twice with 3 ml of water,
and dried using vacuum. The crude product was purified by
the crystallization from methanol to provide 7, 40-di-O-
acetylisoxanthohumol (9) as white crystals (92.1 mg,
74.1% yield, mp = 140–141C, Rf = 0.68, CHCl3:MeOH,
99:1). 1H NMR (300 MHz, acetone-d6) d (ppm): 1.58 and
1.61 (d, 6H, J = 1.4 Hz, CH3-4
00 and CH3-500); 2.27 (s, 3H,
C-40–COOCH3); 2.31 (s, 3H, C-7–COOCH3); 2.78 (dd, 1H,
J = 16.3 Hz, J = 3.1 Hz, CH-3); 3.06 (dd, 1H, J = 16.3
Hz, J = 12.9 Hz, CH-3); 3.19 (d, 2H, J = 7.02 Hz, CH2-
100); 3.80 (s, 3H, C- 5–O–CH3); 5.09 (tsept, 1H, J = 7.1 Hz,
J = 1.4 Hz, CH-200); 5.59 (dd, 1H, J = 12.9 Hz,
J = 2.9 Hz, CH-2); 6.49 (s, 1H, CH-6); 7.21 (d, 2H,
J = 8.6 Hz, CH-30 and CH-50); 7.62 (d, 2H, J = 8.5 Hz,
CH-20 and CH-60). IR (KBr) cm-1: 2964, 2927, 1759,
1687, 1593, 1510, 1477, 1369, 1213, 1170, 1093, 837.
C25H26O7 (438.48): calcd. C 68.48, H 5.98; found C 68.58,
H 6.10.
7,40-Di-O-palmitoylisoxanthohumol (10) To a solution of
100 mg (0.282 mmol) of isoxanthohumol and 0.28 ml
(2.1 mmol) of Et3N in 5.7 ml of anhydrous THF was added
dropwise palmitoyl chloride (155 mg, 0.594 mmol). After
12 h of stirring at room temperature the reaction medium was
shaken with 30 ml of cold water (*0C), extracted with die-
thyl ether (3 9 10 ml), dried over anhydrous Na2SO4, and
concentrated. The resulting residue was purified by column
chromatography (hexane:Et2O:MeOH, 5:5:1) to give 191.2
mg (81.6% yield) of 7,40-di-O-palmitoylisoxanthohumol (10)
as white crystals (mp = 71–73C, Rf = 0.86, CHCl3:MeOH,
95:5). 1H NMR (300 MHz, acetone-d6) d (ppm): 0.87 (t, 6H,
J = 6.9 Hz, C-7- and C-40–OOC(CH2)14CH3); 1.28 (s, 44H,
C-7- and C-40–OOC(CH2)3(CH2)11CH3); 1.40 (m, 4H, J =
6.9 Hz, C-7- and C-40–OOC(CH2)2CH2(CH2)11CH3); 1.59 (d,
6H, J = 1.2 Hz, CH3-4
00 and CH3-500); 1.73 (kwintet, 4H,
J = 7.3 Hz, C-7- and C-40–OOCCH2CH2(CH2)12CH3); 2.60
and 2.64 (two t, 4H, J = 7.3 Hz, C-7- and C-40–OO-
CCH2(CH2)13CH3); 2.78 (dd, 1H, J = 16.3 Hz, J = 3.0 Hz,
CH-3); 3.07 (dd, 1H, J = 16.3 Hz, J = 12.9 Hz, CH-3); 3.19
(d, 2H, J = 6.7 Hz, CH2-1
00); 3.80 (s, 3H, C-5–OCH3); 5.08
(tsept, 1H, J = 6.7 Hz, J = 1.2 Hz, CH-2
00); 5.60 (dd, 1H,
J = 12.9 Hz, J = 3.0 Hz, CH-2); 6.47 (s, 1H, CH-6); 7.20 (d,
2H, J = 8.5 Hz, CH-30 and CH-50); 7.62 (d, 2H, J = 8.5 Hz,
CH-20 and CH-60). IR (KBr) cm-1: 3184, 2919, 2850, 1759,
1688, 1589, 1510, 1468, 1376, 1265, 1139, 1102, 844, 721.
C53H82O7 (831.24): calcd. C 76.58, H 9.94; found C 76.48, H
10.14.
Demethylation of isoxanthohumol derivatives
General procedure Each time 50 mg of compounds (4–10)
were demethylated.
A solution of I2 (3 eq., 99.5 mg, 0.393 mmol) in anhy-
drous Et2O (3.5 ml) and Mg (6 eq., 19.1 mg, 0.786 mmol),
taken in the round-bottomed flask and protected from light,
was stirred at room temperature until the reaction mixture
turned colorless (1.5 h). The resulting mixture of magne-
sium iodide etherate was separated from unreacted Mg and
transferred via syringe under N2 into the two-neck flask
(50 ml), equipped with condenser, containing 50 mg of
substrate [4 (1 eq., 0.131 mmol)-10] in anhydrous THF
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(9 ml). The reaction mixture was stirred and refluxed for
12 h and afterward the solvent was evaporated under
reduced pressure. Then, 1 ml of THF and saturated solution
of NH4Cl (10 ml) were added and the whole mixture was
extracted with CH2Cl2 (3 9 5 ml). The combined extracts
were dried over anhydrous Na2SO4 and the solvent was
removed under reduced pressure to give crude product.
After purification by column chromatography on silica gel
(see Table 1) the products (11–15) were obtained.
7,40-di-O-methyl-8-prenylnaringenin (11) Yield 61.3%,
mp = 105–107C, Rf = 0.32 (CHCl3:hexane, 7:3), light-
white solid. The 1H NMR and IR spectroscopic data were
in agreement with those reported in the literature (Cano
et al., 2006; Siddiqui et al., 2003).
7-O-pentyl-8-prenylnaringenin (12) Yield 84.8%, mp =
132–134C, Rf = 0.67 (CHCl3:MeOH), 97:3, white crystals.
1H NMR (300 MHz, acetone-d6) d (ppm): 0.93 (t, 3H,
J = 7.3 Hz, C-7–O(CH2)4CH3); 1.41 (m, 2H, C-7–
O(CH2)3CH2CH3); 1.49 (m, 2H, C-7–O(CH2)2CH2CH2CH3);
1.61 (d, 6H, J = 1.4 Hz, CH3-4
00 and CH3-500); 1.82 (m, 2H,
C7–OCH2CH2(CH2)2CH3); 2.79 (dd, 1H, J = 17.0 Hz,
J = 3.0 Hz, CH-3); 3.16 (dd, 1H, J = 17.0 Hz, J = 12.6 Hz,
CH-3); 3.22 (d, 2H, J = 7.2 Hz, CH2-1
00); 4.08 (t, 2H,
J = 6.3 Hz, C-7–OCH2(CH2)3CH3); 5.15 (tsept, 1H, J =
7.2 Hz, J = 1.4 Hz, CH-200); 5.46 (dd, 1H, J = 12.6 Hz,
J = 3.0 Hz, CH-2); 6.12 (s, 1H, CH-6); 6.90 (d, 2H,
J = 8.5 Hz, CH-30 and CH-50); 7.41 (d, 2H, J = 8.5 Hz, CH-
20 and CH-60); 8.51 (s, 1H, C-40–OH); 12.24 (s, 1H, C-5–OH).
IR (KBr) cm-1: 3260, 2955, 2926, 2855, 1638, 1616, 1592,
1520, 1467, 1364, 1229, 1094, 832. C25H30O5 (410.51): calcd.
C 73.15, H 7.37; found C 73.32, H 7.54.
7,40-Di-O-allyl-8-prenylnaringenin (13) Yield 78.9%,
mp = 103–105C, Rf = 0.84 (CHCl3:MeOH, 99.3:0.7),
pale yellow solid. 1H NMR (300 MHz, acetone-d6) d (ppm):
1.60 (d, 6H, J = 1.3 Hz, CH3-4
00 and CH3-500); 2.82 (dd, 1H,
J = 17.1 Hz, J = 3.1 Hz, CH-3); 3.18 (dd, 1H, J = 17.1
Hz, J = 12.5 Hz, CH-3); 3.24 (d, 2H, J = 7.2 Hz, CH2-1
00);
4.59 and 4.65 (two ddd, 4H, J = 5.1 Hz, J = 1.7 Hz,
J = 1.5 Hz, C-7- and C-40–OCH2CH=CH2); 5.16 (tsept, 1H,
J = 7.2 Hz, J = 1.3 Hz, CH–200); 5.23–5.31 (m, 2H, trans-
C-7- and trans-C-40–OCH2CH=CH2); 5.51 (dd, 1H,
J = 12.5 Hz, J = 3.1 Hz, CH-2); 5.39–5.48 (m, 2H, cis-C-
7- and cis-C-40–OCH2CH=CH2); 6.02–6.16 (m, 2H, C-7-
and C-40–OCH2CH=CH2); 6.12 (s, 1H, CH-6); 7.02 (d, 2H,
J = 8.8 Hz, CH-30 and CH-50); 7.50 (d, 2H, J = 8.8 Hz,
CH-20 and CH-60). IR (KBr) cm-1: 2967, 2911, 2857, 1636,
1587, 1517, 1448, 1378, 1255, 1178, 1118, 1021, 921, 829.
C26H28O5 (420.51): calcd. C 74.26, H 6.71; found C 74.09, H
6.88.
7,40-Di-O-acetyl-8-prenylnaringenin (14) Yield 88.4%,
mp = 139–140C, Rf = 0.84 (CHCl3:MeOH, 98:2), white
solid. 1HNMR and IR spectroscopic data were in agree-
ment with those reported in the literature (Gester et al.,
2001; Huempel et al., 2005; Metz and Schwab, 2007;
Schaefer et al., 2005).
7,40-Di-O-palmitoyl-8-prenylnaringenin (15) Yield
74.6%, mp = 67–69C, Rf = 0.91 (hexane:Et2O:MeOH,
5:5:0.1), white crystals. 1H NMR (300 MHz, acetone-d6) d
(ppm): 0.87 (t, 6H, J = 6.9 Hz, C-7- and C-40–OOC(CH2)14–
CH3); 1.29 (s, 44H, C-7- and C-4
0–OOC(CH2)3(CH2)11–
CH3); 1.40 (m, 4H, J = 6.9 Hz, C-7- and C-4
0–OOC
(CH2)2CH2(CH2)11–CH3); 1.60 (d, 6H, J = 1.3 Hz, CH3-4
00
and CH3-5
00); 1.73 (quintet, 4H, J = 6.9 Hz, C-7- and C-40–
OOCCH2CH2(CH2)12–CH3); 2.60 and 2.64 (two t, 4H,
J = 7.4 Hz, C-7- and C-40–OOCCH2(CH2)13–CH3); 2.96
(dd, 1H, J = 17.2 Hz, J = 3.0 Hz, CH-3); 3.17 (d, 2H,
J = 6.8 Hz, CH2-1
00); 3.32 (dd, 1H, J = 17.2 Hz, J =
13.1 Hz, CH-3); 5.07 (tsept, 1H, J = 6.8 Hz, J = 1.3 Hz, CH-
200); 5.71 (dd, 1H, J = 13.1 Hz, J = 3.0 Hz, CH-2); 6.30 (s,
1H, CH-6); 7.22 (d, 2H, J = 8.5 Hz, CH-30 and CH-50); 7.65
(d, 2H, J = 8.5 Hz, CH-20 and CH-60); 11.87 (s, 1H, C-5–
OH). IR (KBr) cm-1: 3437, 2918, 2850, 1751, 1648, 1624,
1592, 1512, 1469, 1379, 1264, 1149, 1077, 840, 722.
C52H80O7 (817.21): calcd. C 76.43, H 9.87; found C 76.22,
H 10.01.
Antiproliferative activity
The human cell lines of breast cancer (MCF-7), colon ade-
nocarcinoma (HT-29), and leukemia (CCRF/CEM) were
obtained from American Type Culture Collection (Rockville,
Maryland, USA) and maintained in the Cell Culture Collec-
tion at the Institute of Immunology and Experimental Ther-
apy, Wroclaw, Poland. The cells at the density of 105/ml were
cultivated in 96-well plates (Sarstedt, Germany) in 100 ll of
culture medium at 37C in humid atmosphere containing 5%
CO2. In the case of MCF-7 cell lines, the culture medium
Table 1 Eluents for column chromatography for the purification of compounds (11–15)
Compound 11 12 13 14 15
Eluent CHCl3:hexane 70:30 CHCl3:MeOH 99.2:0.8 CHCl3 100 CHCl3:MeOH 99.5:0.5 CHCl3:Et2O 90:10
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consisted of Eagle’s medium (IIET, Wroclaw, Poland) with
addition of 10% fetal bovine serum (FBS, Sigma-Aldrich
Chemie GmbH, Steinheim, Germany), 100 lg/ml strepto-
mycin (Jelfa, Jelenia Go´ra, Poland), 100 U/ml penicillin
(Jelfa, Jelenia Go´ra, Poland), 2 mM L-glutamine (Gibco,
Warsaw, Poland), 1.0 mM sodium pyruvate, 1% amino acid,
and 0.8 mg/l insulin. The cells of HT-29 line were cultured in
the RPMI 1640 and Opti-MEM (1:1) (both from Gibco)
medium with addition of 5% FBS, 100 lg/ml streptomycin,
100 U/ml penicillin, 1 mM sodium pyruvate, and 2 mM
L-glutamine. CCRF/CEM culture medium consisted RPMI
1640, 10% FBS, 100 lg/ml streptomycin, 100 U/ml penicil-
lin and 2 mM L-glutamine.
The compounds were dissolved in acetone (1–4, 8,
and 10) or absolute ethanol (5–7, 9, 11–13) to the concen-
tration of 10 mg/ml, stored at 4C, and diluted in the culture
medium to obtain concentrations from 0.1 to 100 lg/ml. The
controls contained acetone or ethanol at the appropriate
concentrations. The solutions of the synthesized compounds
in 100 ll of culture medium were added after 24 h of
incubation. The sulphorhodamine B (SRB, Sigma-Aldrich
Chemie GmbH, Steinheim, Germany) assay for MCF-7
and HT-29 cells and the 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium (MTT) assay (Sigma–Aldrich, Ger-
many) for CCRF/CEM cells were executed. Assays were
performed after 72 h of continuous exposure of the culti-
vated cells to varying concentrations of test compounds
according to the methods described by Skehan et al. (1990)
and Marcinkowska et al. (1998), using a Multiskan RC
photometer (Labsystems, Helsinki, Finland). The readings
were recorded at 540 and 570 nm, respectively. Each com-
pound at all the concentrations was investigated in tripli-
cates. Each set of experiments was repeated 3–5 times.
SRB assay
The cells were attached to the bottom of plastic wells by
gently layering cold 50% trichloroacetic acid (TCA) on the
top of the culture medium in each well. The plates were
stored at 4C for 1 h and washed five times with tap water.
The cells fixed with TCA were treated for 30 min with 0.4%
solution of sulforhodamine B in 1% acetic acid. Then, the
cells were washed four times with 1% acetic acid. The
protein-bound dye was extracted with 10 mM unbuffered
Tris base. Optical density (k = 540 nm) was determined in
a microplate reader Multiskan RC photometer.
MTT assay
Culture medium was gently removed from each well and
cells were incubated for 4 h at 37C with 20 ll MTT
solution (5 mg/ml). Then, 80 ll of the mixture that con-
tained 67.5 g sodium dodecyl sulfate and 225 ml dimeth-
ylformamide in 275 ml distilled water were added. After
24 h crystals of formazan were solubilized and the optical
densities of the samples were read on a Multiskan RC
photometer at 570 nm.
Results and discussion
Chemistry
The main goal of this research was investigation of the
demethylation reaction of substituted isoxanthohumols (4–10)
to provide 8-prenylnaringenins (11–15). The investigated























































Xanthohumol, the substrate in the isoxanthohumol
synthesis, was isolated from carbon dioxide-extracted-hops
(Marynka variety), purified and transformed into iso-
xanthohumol as described previously (Anioł et al., 2008).
As model substrates for demethylation, methyl, n-pen-
tyl, allyl, acetyl, and palmitoyl derivatives of 2 were
selected. They had different chain lengths. It was assumed
that the reactivity of homologous series of compounds
should be similar, as well as reactivity of monosubstituted
isoxanthohumol derivatives in comparison to disubstituted.
For this reason, alkylating and acylating agents were used
in high quantity to obtain disubstituted derivatives of 2 as a
goal of synthesis.
Methyl ethers (4 and 5) were synthesized using excess
of methyl iodide with 69.4 and 8.8% yield, respectively
(Table 2, Entries 1a and 1b). During the course of reaction,
it was observed that the formation of 7-O-methyl com-
pound (5), which was methylated to get a dimethyl com-
pound (4). There was a characteristic shift of the signal for
C-6 proton of substrate (2) from 6.21 to 6.36 ppm for
compound (5) on the NMR spectrum. It was caused by the
substitution of C-7–OH group by a methoxy group. The
chemical shifts of C-30-, C-50- and C-20-, C-60-protons were
exactly the same in both the compounds (d = 6.89 and
7.38 ppm, respectively). The formation of products of
cleavage of C ring leading to xanthohumol derivatives, as
reported for methylation of 8-prenylnaringenin with
Me2SO4 (Jain et al., 1978). In case of prenylation (Table 2,
Entries 2a and 2b), the order of alkylation was the same as
that of compounds (4 and 5). The first product, 7-O-pent-
ylisoxanthohumol (6) was formed with 27.6% yield
(d = 6.34 (CH-6), 6.89 (CH-30, CH-50) and 7.38 ppm
(CH-20, CH-60), and 7, 40-O-dipentylisoxanthohumol (7)
with 13.6% yield. The best yield of alkylation was
observed during the synthesis of the diallyl compound (8,
Table 2, Entry 3). Diacyl compounds (9 and 10) were
obtained with 74.1 and 81.6% yield, respectively (Table 2,
Entries 4 and 5).
Demethylation reactions were carried out according to
published procedure (Anioł et al., 2008). Each time 50 mg
of substrate was taken. The rest of the reagents were
used proportionally in molar quantities. Demethylation of
trimethoxy derivative (4) confirmed that the reaction of
methyl-aryl ethers with magnesium iodide etherate occur-
red mainly at ortho-position in relation to acyl group. The
main product of demethylation (11) was obtained with
yield of 61.3% (Table 2, Entry 6) but during the reaction
course, the formation of complicated mixture of by-prod-
ucts was observed, which was confirmed by TLC and
HPLC. This reaction was not as clean as that of demeth-
ylation of isoxanthohumol (Anioł et al., 2008). The 1H
NMR spectrum of 11 showed the lack of signal of
C-8–OCH3 protons at 3.86 ppm, and the presence of signal
at 12.25 ppm for the proton of C-8–OH group involved in a
strong intramolecular hydrogen bond. A quite similar effect
as above was observed for the rest of the synthesized
8-prenylnaringenin derivatives. All the spectra were
recorded within 1–2 h after the sample preparation in
Table 2 Synthesis of 7-O- and 40-O-substituted isoxanthohumols (4–10), their demethylation to 8-prenylnaringenins (11–15) and antiprolif-
erative activity in vitro
Entry Substrate Product Yield[a] [%)] 7-O-R 40-O-R Cell line/ID50 (lg/ml)±SD
MCF-7 HT-29 CCRF/CEM
– 1 – – – 4.7 ± 0.6 3.8 ± 0.6 4.1 ± 0.5
1 2 – – – 9.4 ± 0.4 32.6 ± 0.3 18.2 ± 1.9
2 3 – – – 19.4 ± 1.9 33.2 ± 0.8 24.2 ± 1.4
1a 2 4 69.4 Me Me 6.6 ± 0.6 6.0 ± 1.2 5.0 ± 1.7
1b 2 5 8.8 Me H Not tested Not tested Not tested
2a 2 6 27.6 Pentyl H 8.3 ± 1.2 6.9 ± 0.8 5.4 ± 0.9
2b 2 7 13.6 Pentyl Pentyl 7.1 ± 0.6 8.2 ± 1.3 4.3 ± 0.7
3 2 8 81.2 Allyl Allyl 5.2 ± 0.1 6.2 ± 1.1 2.7 ± 0.5
4 2 9 74.1 Ac Ac 16.9 ± 2.3 32.1 ± 0.7 23.3 ± 1.1
5 2 10 81.6 Palmitoyl Palmitoyl Negative Negative Negative
6 4 11 61.3 Me Me 36.9 ± 6.2 Negative Negative
7 6 12 84.8 Pentyl H 3.9 ± 0.2 10.0 ± 2.9 4.8 ± 0.4
8 8 13 78.9 Allyl Allyl Negative Negative Negative
9 9 14 88.4 Ac Ac 28.0 ± 2.6 36.1 ± 3.8 37.0 ± 3.5
10 10 15 74.6 Palmitoyl Palmitoyl Negative Negative Negative




acetone-d6. When the spectrum was accumulated on the next
day or later the signals for the hydroxyl protons disappeared
because of the hydrogen deuterium exchange. Compound
(11) was also isolated from Azadirachta indica (Siddiqui
et al., 2003) and Esenbeckia berlandieri ssp. Acapulcensis
(Cano et al., 2006). Substrate (4) used in the above reaction
was present in hops in low quantity (Faltermeier et al., 2006;
Oosterveld et al., 2002). For testing whether the demethyl-
ation depends on chain length of alkyl group, pentyl deriv-
ative of isoxanthohumol (6) was synthesized.
Demethylation of 7-O-pentylisoxanthohumol (6) to
product (12) occurred with high yield of 84.8% (Table 2,
Entry 7).
Cleavage of allyl ethers of alcohols and phenols was
observed using lewis acids such as the CeCl3–NaI system
(Bartoli et al., 2001; Thomas et al., 1999). Compound (8) was
synthesized to check whether its demethylation was affected
by deallylation. There was a possibility that MgI2, composed
with magnesium (typical Lewis acid) and iodine (strong
nucleophile) could be similar in action to CeCl3–NaI system.
We did not observe the allyl–aryl ether cleavage and the
desired product (13) were obtained with good 78.9% yield
(Table 2, Entry 7). As in the case of alkyl ethers of iso-
xanthohumol, for testing whether the yield of demethylation
depends on chain length of acyl group, diacetyl and dipalmi-
toyl derivatives of isoxanthohumol (9 and 10) were synthe-
sized. These compounds, as representatives of esters,
commonly applied as prodrugs, underwent demethylation
with magnesium iodide etherate (Table 2, Entries 9 and 10).
The products, 8-prenylnaringenins (14 and 15) were obtained
with 88.4 and 74.6% yield, respectively. Thus, introduction of
alkyl, allyl or acyl group into isoxanthohumol moiety did not
significantly influence the demethylation reaction and all the
synthesized compounds were stable during the course of
reactions. Nevertheless, during the optimization of the iso-
xanthohumol demethylation (Anioł et al., 2008) to 8-pren-
ylnaringenin the instability of reagents was observed, which
could be associated with the known low stability of flavonoids.
Investigations conducted by a group of Wilhelm and
Wessjohann (2006) showed that demethylation of such
compounds as isoxanthohumol was very difficult to carry
out. Among the 17 demethylating agents only Sc(OTf)3/KI
system worked with high yield. Our previous investigations
demonstrated that this system could be replaced with
MgI2 9 2Et2O to obtain 8-prenylnaringenin with 93% of
yield. Now, we showed that this cheap, non toxic, easy to
prepare and use agent could be applied in demethylation of
acyl, alkyl, and allyl derivatives of isoxanthohumol.
Antiproliferative activity, in vitro
The synthesized compounds were examined for their
antiproliferative activity in vitro against the human cell
lines of breast cancer (MCF-7), colon adenocarcinoma
(HT-29), and leukemia (CCRF/CEM). The results pre-
sented in Table 2 are expressed as the concentration in
lg/ml leading to 50% inhibition of tumor cells proliferation
(ID50-dose) in comparison with the untreated ones.
Acetone or ethanol, which was used as solvents, did not
show any inhibitory effect on cell proliferation, even
in the largest concentrations used. Xanthohumol (1),
isoxanthohumol (2), and 8-prenylnaringenin (3), studied
previously against selected tumor cell lines (Brunelli et al.,
2007, 2009; Monteiro et al., 2007; Zanoli and Zavatti,
2008), were used as reference compounds. The two newly
synthesized compounds (8 and 12) exhibited higher anti-
proliferative activity than the most active xanthohumol (1)
against CCRF/CEM (2.7 lg/ml) and MCF-7 (3.9 lg/ml)
cell lines and approaching the cytotoxic activity criterion
ID50 B 4 lg/ml for new anticancer synthetic substances.
The conducted investigations showed that, 7,40-di-O-
methyl-, 7,40-di-O-pentyl-, and 7,40-di-O-allyl- derivatives
of isoxanthohumol (4, 7, 8) were significantly more active
than parental isoxanthohumol (2) (9.4–32.6 lg/ml) against
all investigated cells (2.7–6.6 lg/ml). On the other hand,
diacyl derivatives (9: 16.9–32.1 lg/ml and 10: ID50 [
100 lg/ml) did not show any significant activity. Among the
8-prenylnaringenin derivatives, the most active compound
was 7-O-pentyl-8-prenylnaringenin (12). This compound
possessed the activity against the cells of MCF-7 (3.9 lg/
ml), HT-29 (10.0 lg/ml), and CCRF/CEM (4.8 lg/ml) more
than three times higher than 8-prenylnaringenin (3), 19.4,
33.2, 24.2 lg/ml, respectively. The rest of the derivatives of
8-prenylnaringenin (11, 13–15) possessed low activity or
were inactive (ID50 [ 100 lg/ml).
Conclusion
In conclusion, the presented simple methodology of
demethylation of isoxanthohumol derivatives via the for-
mation of magnesium iodide etherate, offers an easy
transformation route for 8-prenylnaringenin derivatives
synthesis using xanthohumol as a starting material, which
can be applied to several functional groups. Although the
yields obtained (61.3–88.4%) were not as good as in case
of demethylation of unsubstituted isoxanthohumol, the
method was still easy, cheap and could be carried out in
mild conditions. The synthesized compounds showed
antiproliferative activity against the human cell lines of
breast cancer (MCF-7), colon adenocarcinoma (HT-29),
and leukemia (CCRF/CEM). The most active compound
possessed activity of 2.7 lg/ml against leukemia cell lines.
The developed demethylation protocol could be used in the
synthesis of various potentially bioactive 8-prenylnaringe-
nin derivatives and can be of use in the combinatorial
Med Chem Res
123
chemistry to prepare libraries of such compounds. It would
also help in proper utilization of the spent hops, the waste
product of hop industry.
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